MONONUCLEAR PHAGOCYTE-DERIVED GROWTH FACTOR
MONONUCLEAR PHAGOCYTE-DERIVED GROWTH FACTOR
批准号:
3169263
负责人:
G. YANCEY GILLESPIE
金额:
$12.31万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-06-01 至 1988-05-30
关键词:
affinity chromatography cell differentiation cell growth regulation cell population study cell sorting epidermal growth factor fibroblast growth factor gel electrophoresis gene expression high performance liquid chromatography hybridomas inflammation macrophage macrophage activating factor membrane activity molecular cloning monoclonal antibody monocyte monokines neoplastic transformation phagocytes radioimmunoassay radiotracer tissue /cell culture tritium wound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of this research is to develop our fundamental knowledge of the
basic mechanism(s) by which mononuclear phagocytes regulate proliferation
of various normal cell types. Our findings to date suggest that
macrophages and macrophage-like cell lines elaborate specific soluble
factor(s) that can cause quiescent fibroblasts to initiate traverse of the
cell cycle. Operationally, this monokine(s) is a "competence" factor,
similar in its action to other known competence factors (platelet-derived
growth factor and fibroblast growth factor) but biochemically distinct from
both. We have concentrated our efforts on purification of the
macrophage-derived competence factor (MDCF) from spent supernates of
cultured P388D1, a mouse macrophage-like cell line that elaborates generous
amounts of MDCF in addition to another growth factor, interleukin-1 (IL-1).
We have greatly simplified purification by adapting P388D1 cells to grow
continuously serum-free in a defined medium. Serial application of
ultrafiltration, gel filtration, and ion exchange chromatography has
clearly separated MDCF and IL-1, both in terms of biochemical/biophysical
properties and biological activities. Analysis by silver-stained SDS-PAGE
slab gels reveals two major bands of protein that correspond to MDCF
activity and one that corresponds to IL-1 activity. Companion studies of
affinity-purified IL-1 confirm our findings that MDCF and IL-1 are distinct
biochemical and biological entities. Using this greatly purified MDCF, we
are now beginning to develop specific antisera using rabbits and monoclonal
antibodies using rat-mouse hybridomas to identify and quantify MDCF for in
vivo and in vitro experiments. Our aim is to compare this monokine with
other known growth factors as an initial step in using these as probes to
dissect the cellular events associated with proliferation. The results
obtained should provide a foundation for definitive studies on the relation
of macrophage-derived competence factor production in vivo to lesions
characterized by mononuclear phagocyte accumulation, extensive fibroplasia,
and collagen deposition. (J)
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Growth factors derived from a human malignant glioma cell line, U-251MG.
源自人类恶性神经胶质瘤细胞系 U-251MG 的生长因子。
DOI:
10.1007/bf00172915
发表时间:
1989
期刊:
Journal of neuro-oncology
影响因子:
3.9
作者:
[Kuratsu,J, Estes,JE, Yokota,S, MahaleyJr,MS, Gillespie,GY]
通讯作者:
Gillespie,GY
Interferon-alpha and -gamma promote myeloid differentiation of HL-60, a human acute promyelocytic leukemia cell line.
干扰素-α 和-γ 促进人类急性早幼粒细胞白血病细胞系 HL-60 的骨髓分化。
DOI:
--
发表时间:
1984
期刊:
Journal of biological response modifiers
影响因子:
--
作者:
[Buessow,SC, Gillespie,GY]
通讯作者:
Gillespie,GY
Macrophage-derived growth factor for fibroblasts and Interleukin-1 are distinct entities.
成纤维细胞的巨噬细胞衍生生长因子和 Interleukin-1 是不同的实体。
DOI:
10.1002/jlb.35.1.115
发表时间:
1984
期刊:
Journal of leukocyte biology
影响因子:
5.5
作者:
[Estes,JE, Pledger,WJ, Gillespie,GY]
通讯作者:
Gillespie,GY
Tumoricidal activity of an acute promyelocytic leukemia cell line (HL-60) is augmented by human interferon alpha.
人干扰素 α 增强了急性早幼粒细胞白血病细胞系 (HL-60) 的杀肿瘤活性。
DOI:
10.1016/0145-2126(84)90101-2
发表时间:
1984
期刊:
Leukemia research
影响因子:
2.7
作者:
[Buessow,SC, Gillespie,GY, Mahaley,MS]
通讯作者:
Mahaley,MS
Membranes from T and B lymphocytes have different patterns of tyrosine phosphorylation.
T 和 B 淋巴细胞的膜具有不同的酪氨酸磷酸化模式。
DOI:
10.1073/pnas.81.8.2347
发表时间:
1984
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Earp,HS, Austin,KS, Buessow,SC, Dy,R, Gillespie,GY]
通讯作者:
Gillespie,GY
共 8 条
Glioblastoma tumor microenvironmental influence on acquired and inherent cancer therapy resistance.
-
批准号:10046398
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2018
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
-
批准号:9455636
-
项目类别:
-
资助金额:$55.93万
-
财政年份:2017
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Experimental Glioma Animal Models Core
-
批准号:8299607
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2011
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
-
批准号:8540977
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2011
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
-
批准号:8337752
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2011
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
-
批准号:8147551
-
项目类别:
-
资助金额:$90.0万
-
财政年份:2011
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7908624
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2009
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Experimental Glioma Animal Models Core
-
批准号:7747240
-
项目类别:
-
资助金额:$18.02万
-
财政年份:2009
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7454560
-
项目类别:
-
资助金额:$107.3万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7253509
-
项目类别:
-
资助金额:$12.48万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:6772544
-
项目类别:
-
资助金额:$233.77万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7848492
-
项目类别:
-
资助金额:$23.31万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7117060
-
项目类别:
-
资助金额:$10.36万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:6919955
-
项目类别:
-
资助金额:$234.39万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7463018
-
项目类别:
-
资助金额:$12.93万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7077704
-
项目类别:
-
资助金额:$233.14万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY
-
批准号:6502919
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2001
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY
-
批准号:6324642
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2000
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY
-
批准号:6103256
-
项目类别:
-
资助金额:$21.52万
-
财政年份:1999
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY
-
批准号:6269783
-
项目类别:
-
资助金额:$19.95万
-
财政年份:1998
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
海外基金